Altamira Therapeutics Ltd.: Altamira Therapeutics' SemaPhore RNA Delivery Platform Drives Effective Treatment of Osteoarthritis with mRNA in Animal Model : vimarsana.com

Data to be presented at Osteoarthritis Research Society International World Congress in Denver March 17-20, 2023Animal study shows effective attenuation of osteoarthritis progression and functional improvement

Related Keywords

Bermuda , Florida , United States , Switzerland , Denver , Colorado , Dennis Riedl , Samuel Wickline , Securities Exchange Commission , Washington University School Of Medicine St , Company Nasdaq , Altamira Therapeutics Ltd View , Us Centers For Disease , Securities Exchange , Osteoarthritis Research Society International World Congress , Company Semaphore , World Congress , Osteoarthritis Research Society International , University Of South Florida Tampa , Denver March , Altamira Therapeutics , Research Society International , Washington University School , South Florida , Disease Control , Chief Scientific Adviser , Securities Act , Securities Exchange Act , Altamira Therapeutic , Altamira Therapeutic Annual Report , Altamira , Herapeutics , Semaphore , Elivery , Latform , Rives , Ffective , Reatment , Steoarthritis , Rna , Nimal , Odel ,